Guardant Infinity™
Use
Guardant Infinity™ is designed to deliver comprehensive and multidimensional molecular profiling in oncology through combined genomic and epigenomic analysis from minimally invasive liquid (blood) or tissue samples. The liquid core module covers SNV/Indels, copy number amplifications and losses, fusions, tumor mutation burden (bTMB) and microsatellite instability (MSI), along with DNA methylation–based quantification of tumor fraction. The tissue core module provides similarly extensive profiling, including SNV/Indels, copy number variations, fusions/rearrangements, TMB, MSI, promoter methylation regions, RNA-based fusion detection and PD‑L1 expression, enabling robust insights for precision oncology and response monitoring.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
7 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
≥2 mL of plasma
Minimum Volume
Not provided
Other tests from different labs that may be relevant
